Cargando…

Immune complexes in chronic Chagas disease patients are formed by exovesicles from Trypanosoma cruzi carrying the conserved MASP N-terminal region

The exovesicles (EVs) are involved in pathologic host-parasite immune associations and have been recently used as biomarkers for diagnosis of infectious diseases. The release of EVs by Trypanosoma cruzi, the causative agent of Chagas disease, has recently been described, with different protein cargo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz Lozano, Isabel María, De Pablos, Luis Miguel, Longhi, Silvia Andrea, Zago, María Paola, Schijman, Alejandro Gabriel, Osuna, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353755/ https://www.ncbi.nlm.nih.gov/pubmed/28294160 http://dx.doi.org/10.1038/srep44451

Ejemplares similares

The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles
por: De Pablos, Luis Miguel, et al.
Publicado: (2016)

Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease
por: Lozano, Noelia, et al.
Publicado: (2023)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama
por: Ledezma, Alexa Prescilla, et al.
Publicado: (2020)

Correction: Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama
por: Prescilla-Ledezma, Alexa, et al.
Publicado: (2021)

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
por: Zingales, Bianca, et al.
Publicado: (2014)

Characterization and functional analysis of the proteins Prohibitin 1 and 2 in Trypanosoma cruzi
por: Ibarrola-Vannucci, Ana K., et al.
Publicado: (2021)

Transcriptional and phenotypical heterogeneity of Trypanosoma cruzi cell populations
por: Seco-Hidalgo, Víctor, et al.
Publicado: (2015)

Detection of anti-Trypanosoma cruzi antibodies by chimeric antigens in chronic Chagas disease-individuals from endemic South American countries
por: Del-Rei, Rodrigo Pimenta, et al.
Publicado: (2019)

Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients
por: Muñoz-Calderón, Arturo, et al.
Publicado: (2021)

Loop-Mediated Isothermal Amplification of Trypanosoma cruzi DNA for Point-of-Care Follow-Up of Anti-Parasitic Treatment of Chagas Disease
por: Muñoz-Calderón, Arturo A., et al.
Publicado: (2022)

The MASP Family of Trypanosoma cruzi: Changes in Gene Expression and Antigenic Profile during the Acute Phase of Experimental Infection
por: dos Santos, Sara Lopes, et al.
Publicado: (2012)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

Genomic organization and expression profile of the mucin-associated surface protein (masp) family of the human pathogen Trypanosoma cruzi
por: Bartholomeu, Daniella C., et al.
Publicado: (2009)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Lineage Analysis of Circulating Trypanosoma cruzi Parasites and Their Association with Clinical Forms of Chagas Disease in Bolivia
por: del Puerto, Ramona, et al.
Publicado: (2010)

Congenital Transmission of Trypanosoma cruzi: A Review About the Interactions Between the Parasite, the Placenta, the Maternal and the Fetal/Neonatal Immune Responses
por: Kemmerling, Ulrike, et al.
Publicado: (2019)

Emerging and reemerging forms of Trypanosoma cruzi transmission
por: Shikanai Yasuda, Maria Aparecida
Publicado: (2022)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Trypanosoma cruzi (Chagas' disease agent) reduces HIV-1 replication in human placenta
por: Dolcini, Guillermina Laura, et al.
Publicado: (2008)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
por: Wang, Wei, et al.
Publicado: (2021)

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease
por: Zingales, Bianca, et al.
Publicado: (2022)

Experimental Trypanosoma cruzi Infection and Chagas Disease—A Word of Caution
por: Talvani, André, et al.
Publicado: (2023)

Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
por: Teixeira, Antonio R. L., et al.
Publicado: (2011)

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
por: Albareda, María Cecilia, et al.
Publicado: (2015)

Participation of Central Muscarinic Receptors on the Nervous Form of Chagas Disease in Mice Infected via Intracerebroventricular with Colombian Trypanosoma cruzi Strain
por: de Assis, Gabriela Maira Pereira, et al.
Publicado: (2021)

Trypanocide Treatment of Women Infected with Trypanosoma cruzi and Its Effect on Preventing Congenital Chagas
por: Fabbro, Diana L., et al.
Publicado: (2014)

Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2020)

A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease
por: Nagarkatti, Rana, et al.
Publicado: (2020)

Genetic polymorphism of Trypanosoma cruzi bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial
por: Ramírez, Juan Carlos, et al.
Publicado: (2021)

Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease
por: Mukherjee, Shankar, et al.
Publicado: (2011)

Métodos Diagnósticos para Trypanosoma cruzi en la enfermedad de Chagas : /
por: López Jiménez, Carlos Felipe
Publicado: (2015)

Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019)

Fatal acute Chagas disease by Trypanosoma cruzi DTU TcI, Ecuador
por: Calvopina, Manuel, et al.
Publicado: (2020)

Nationwide Exposure of U.S. Working Dogs to the Chagas Disease Parasite, Trypanosoma cruzi
por: Meyers, Alyssa C., et al.
Publicado: (2020)

Trypanosoma cruzi parasitemia in chronic Chagas disease: Insights from hierarchical modeling
por: Abad-Franch, Fernando
Publicado: (2022)

Conservation and divergence within the clathrin interactome of Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uoa6jngp20p6p0mfnv30chae17